Bendele AM[au] - Search Results

Year	Number of Results
1984	1
1985	2
1986	1
1987	2
1988	4
1989	4
1990	6
1991	7
1992	4
1993	4
1994	4
1996	2
1997	1
1998	1
1999	3
2000	4
2001	1
2002	2
2003	1
2004	1
2005	3
2006	2
2007	1
2009	3
2010	1
2014	1
2015	1
2016	3
2017	4
2018	3
2019	3
2021	1
2022	0

1

The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the rat.

Gerwin N, Bendele AM, Glasson S, Carlson CS. Gerwin N, et al. Among authors: bendele am. Osteoarthritis Cartilage. 2010 Oct;18 Suppl 3:S24-34. doi: 10.1016/j.joca.2010.05.030. Osteoarthritis Cartilage. 2010. PMID: 20864021 Free article.

2

Development of a selective matrix metalloproteinase 13 (MMP-13) inhibitor for the treatment of Osteoarthritis.

Bendele AM, Neelagiri M, Neelagiri V, Sucholeiki I. Bendele AM, et al. Eur J Med Chem. 2021 Nov 15;224:113666. doi: 10.1016/j.ejmech.2021.113666. Epub 2021 Jun 29. Eur J Med Chem. 2021. PMID: 34245949 Free PMC article.

3

Physical inactivity and knee osteoarthritis in guinea pigs.

Wallace IJ, Bendele AM, Riew G, Frank EH, Hung HH, Holowka NB, Bolze AS, Venable EM, Yegian AK, Dingwall HL, Carmody RN, Grodzinsky AJ, Lieberman DE. Wallace IJ, et al. Among authors: bendele am. Osteoarthritis Cartilage. 2019 Nov;27(11):1721-1728. doi: 10.1016/j.joca.2019.07.005. Epub 2019 Jul 11. Osteoarthritis Cartilage. 2019. PMID: 31302235 Free article.

4

Animal models of osteoarthritis.

Bendele AM. Bendele AM. J Musculoskelet Neuronal Interact. 2001 Jun;1(4):363-76. J Musculoskelet Neuronal Interact. 2001. PMID: 15758487 Free article.

5

Toxicology Evaluation of Drugs Administered via Uncommon Routes: Intranasal, Intraocular, Intrathecal/Intraspinal, and Intra-Articular.

Emami A, Tepper J, Short B, Yaksh TL, Bendele AM, Ramani T, Cisternas AF, Chang JH, Mellon RD. Emami A, et al. Among authors: bendele am. Int J Toxicol. 2018 Jan/Feb;37(1):4-27. doi: 10.1177/1091581817741840. Epub 2017 Dec 21. Int J Toxicol. 2018. PMID: 29264927 Free PMC article.

6

Treatment of rheumatoid arthritis with PEGylated recombinant human soluble tumour necrosis factor receptor type I: a clinical update.

Davis MW, Feige U, Bendele AM, Martin SW, Edwards CK 3rd. Davis MW, et al. Among authors: bendele am. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i41-3. doi: 10.1136/ard.59.suppl_1.i41. Ann Rheum Dis. 2000. PMID: 11053086 Free PMC article. Review. No abstract available.

7

A synthetic polymeric biolubricant imparts chondroprotection in a rat meniscal tear model.

Wathier M, Lakin BA, Cooper BG, Bansal PN, Bendele AM, Entezari V, Suzuki H, Snyder BD, Grinstaff MW. Wathier M, et al. Among authors: bendele am. Biomaterials. 2018 Nov;182:13-20. doi: 10.1016/j.biomaterials.2018.08.009. Epub 2018 Aug 7. Biomaterials. 2018. PMID: 30099277 Free PMC article.

8

Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases.

Edwards CK 3rd, Martin SW, Seely J, Kinstler O, Buckel S, Bendele AM, Ellen Cosenza M, Feige U, Kohno T. Edwards CK 3rd, et al. Among authors: bendele am. Adv Drug Deliv Rev. 2003 Sep 26;55(10):1315-36. doi: 10.1016/s0169-409x(03)00112-1. Adv Drug Deliv Rev. 2003. PMID: 14499710 Review.

9

Spontaneous cartilage degeneration in guinea pigs.

Bendele AM, Hulman JF. Bendele AM, et al. Arthritis Rheum. 1988 Apr;31(4):561-5. doi: 10.1002/art.1780310416. Arthritis Rheum. 1988. PMID: 3358814

10

Hepatocellular proliferation in ibuprofen-treated mice.

Bendele AM, Hulman JF, White S, Brodhecker C, Bendele RA. Bendele AM, et al. Toxicol Pathol. 1993;21(1):15-20. doi: 10.1177/019262339302100102. Toxicol Pathol. 1993. PMID: 8378703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results